In order to investigate the relation of weight loss and intravenous hyperalimentation therapy to low T3 syndrome, serum T3, T4. rT3 and TBG were determined by radioimmunoassay in 105 cancer patients.
It is already known (Sullivan et al., 1973) that many serious systemic diseases are characterized by an unusual change in circulating thyroid hormones. In these cases, a decrease in total and free 3, 5, , an increase in 3, 3', 5'-triiodothyronine (reverse T3, rT3), normal total thyroxine (T4) and normal, low or high free thyroxine (FT4) are frequently observed.
A change in the deiodinative mechanism leads to the clinical situation known as low T3 syndrome characterized by a reduced peripheral conversion of T4 to T3 and a rise in rT3 levels. Low T3 syndrome has been also described in the undernutrition states such as fasting (Croxson and Ibberton, 1977) , anorexia nervosa (Miyai et al., 1975; Spencer KAMIJO et al. Endocrinol. Japon. February 1986 and cancer (Kamijo et al., 1981a) . Studies of low diet therapy in obesity have also demonstrated that carbohydrate plays a very important role in the pathogenesis of low T3 syndrome (Spaulding et al., 1976; Burman et al., 1979) . The present study was undertaken to investigate the relationship of weight loss and hyperalimentation therapy to low T3 syndrome in cancer patients.
Materials and Methods
One hundred and five cancer patients including 58 gastric, 25 colonic, 7 hepatocellular, 7 pancreatic, 5 pulmonary and 3 esophageal cancers were investigated. None of the patients was pretreated with steroid. Serum T3, T4, rT3 and TBG were measured by radioimmunoassay, as previously reported (Kamijo et al., 1981 b) . T3/ T4 ratio was used to evaluate a peripheral conversion of T4 to T3 because of highly significant correlation with its true convesion (Nomura et al., 1974; in preparation (2) Influence of intravenous hyperalimentation therapy on serum T3 and T4 values (Fig. 6) . In three out of 5 cancer patients, serum T3 values increased after the intravenous hyperalimentation therapy, whereas no significant changes in serum T4 values were observed after the therapy. Two patients who died within one day after the final examination showed no significant changes in serum T3 levels before and after hyperalimentation. We have demonstrated that weight loss produced different effects on peripheral conversion of T4 to T3 in cancer patients under age 59 and those over age 60. The results of clinical studies on the influence of hyperalimentation on the serum T3 concentrations lead to the conclusion that glucose plays an important role in the pathogenesis of low T3 syndrome in cancer patients except cases with very poor prognosis who died within one day after the examination. Spaulding et al. (1976) reported that unlike protein and lipid, only carbohydrate maintained normal T3 values during low calory diet in obese subjects. Not only glucose, but fructose also has a similar effect on serum T3 values (Burman et al., 1979) . In contrast, it is pointed out that in cancer patients with weight loss, low T3 syndrome is not based on abnormal metabolic changes in carbohydrate because the blood free fatty acid and alanine decreased but the blood glucose, ketone body, lactic acid, pyruvate as well as insulin and glucagon were all within the normal range (Axelrod et al., 1983) . However our results indicated that the low T3 syndrome in cancer patients was associated with metabolic changes in glucose since the intravenous hyperalimentation therapy induced the normalization of serum T3 values.
It has been also reported that low T3 or low T4 syndrome is closely associated with poor prognosis (Kaptein et al., 1982; Vierhapper et al., 1982) . In the present study, no significant changes in serum T3 were induced by hyperalimentation in cancer patients with very poor prognosis. The results suggests that low T3 syndrome may also be caused by a certain metabolic change associated with poor prognosis in cancer patients.
